Search Medical Condition
Please enter condition
Please choose location
Clear Trial Filters
 

Lung Disease Clinical Trials

A listing of Lung Disease medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (1888) clinical trials

A research study is evaluating the effects of an investigational study medication for heart failure in patients with iron deficiency.

Phase N/A

This is a multicenter, open-label, multi-arm Phase 2 study to evaluate the efficacy and safety of single agent niraparib in patients with locally advanced and metastatic sqNSCLC and of the combination of niraparib and pembrolizumab in locally advanced and metastatic NSCLC (all histologies) patients. 

Phase N/A

People with non-small cell lung cancer are asked to participate in a research study being conducted by White Plains Hospital.

Phase N/A

People with suspicion of lung cancer who are scheduled for a biopsy/other diagnostic procedure are asked to participate in a research study being conducted by Long Island Jewish Medical Center.

Phase N/A

The primary objective of this study is to obtain de-identified, clinically characterized, whole blood specimens for use in assessing new biomarkers for the detection of neoplasms of the lung.

Phase N/A

To evaluate the effect of treatment with omecamtiv mecarbil (OM) compared with placebo on the time to cardiovascular (CV) death or first HF (Heart Failure) event, whichever occurs first, in subjects with chronic HF with reduced ejection fraction (HFrEF) receiving standard of care (SoC) therapy.

Phase N/A

To evaluate the efficacy of the oral soluble guanylate cyclase (sGC) stimulator MK-1242 (vericiguat) in comparison to placebo on a background of standard of care in increasing the time to first occurrence of the composite of CV death or HF hospitalization in subjects with HFrEF.

Phase N/A

People with non-small cell lung cancer are asked to participate in a research study being conducted by White Plains Hospital.

Phase N/A

You must be 40 years of age or older You must have a diagnosis of COPD for at least a year You must currently be treating your COPD with a daily medication for at least 8 weeks prior to starting the study You must be a current or former smoker ...

Phase N/A

This is a research study for chronic obstructive pulmonary disease (COPD). Subjects who meet inclusion criteria will be assigned to one of three doses of tiotropium. Two of these doses will be delivered via a novel inhalation device. The third dose will be delivered by the HandiHaler. This study is ...

Phase N/A